Bangladesh Measles Outbreak: Doctors Fear Post-Eid Surge Amidst Crisis

Bangladesh is currently battling one of its deadliest measles outbreaks in decades, with health officials and doctors expressing significant concern about a potential surge in cases following the recent Eid al-Adha celebrations. As of June 1, 2026, the Directorate General of Health Services (DGHS) reported a staggering 70,936 suspected measles cases since mid-March, with 9,049 laboratory-confirmed infections. The death toll stands at 585, comprising 495 suspected and 90 confirmed measles-related fatalities, primarily affecting children under the age of five. The outbreak, which began in January 2026 in Rohingya refugee camps near the Myanmar border, has rapidly spread, now impacting 58 out of Bangladesh's 64 districts across all eight divisions. The high contagiousness of measles, described as even six times more infectious than COVID-19, means that one infected person can transmit the virus to up to nine out of ten susceptible individuals in close contact. Several critical factors have contributed to this severe public health crisis. A primary cause is the significant decline in measles-rubella (MR) vaccination coverage. The first dose (MR1) coverage dropped slightly to 86% from 88.6% in 2019, while the second dose (MR2) coverage saw a more concerning decrease from 89% to 80.7% by 2023. These figures fall below the 95% vaccination threshold recommended by the World Health Organization (WHO) for achieving herd immunity and preventing outbreaks. The immunity gaps were exacerbated by a nationwide stockout of MR vaccines between 2024 and 2025. This shortage was a consequence of political turmoil in 2024, when student-led protests led to the overthrow of the previous government. The subsequent interim administration reportedly failed to conduct essential supplementary mass vaccination campaigns, with the last such campaign occurring in 2020. UNICEF had repeatedly warned the interim government about the impending vaccine shortages through written communications and numerous meetings with health ministry officials. The impact on Bangladesh's healthcare system has been profound. Hospitals across the country are severely overwhelmed, with local reports showing overcrowded facilities where patients, predominantly young children, are sometimes treated on floors due to a lack of beds. Health facilities face limited isolation capacity, staff shortages, and in some areas, a critical absence of pediatric intensive care units. Mymensingh Medical College Hospital, for instance, reported 44 deaths among children with measles symptoms by June 1, 2026. In response to the escalating crisis, the Government of Bangladesh, with support from WHO, UNICEF, and Gavi, the Vaccine Alliance, launched an emergency nationwide Measles-Rubella (MR) vaccination campaign. This campaign, which began in hotspots on April 5, 2026, and expanded nationwide by May 3, 2026, aims to vaccinate millions of children, with the minimum age for the first dose temporarily lowered to six months to protect the most vulnerable. Alongside vaccination, efforts include strengthening surveillance, epidemiological analysis, and providing Vitamin A supplementation to affected children, which is crucial for preventing severe complications. Despite these efforts, doctors are bracing for a further surge. Millions of Bangladeshis traveled to their hometowns during the recent Eid al-Adha holidays, often without adhering to public health protocols. Experts warn that given the incubation period of 10-14 days, this mass movement is highly likely to lead to an increase in infection rates in the coming weeks. The lack of efficient contact tracing facilities further complicates containment efforts. For India, the outbreak in neighboring Bangladesh presents a significant cross-border health risk. Cities like Jashore and Chapainawabganj, identified as measles hotspots, share busy land crossings with India, increasing the potential for the virus to spread across borders. The WHO's Southeast Asia region is at high risk, and India, despite its generally high vaccination rates, has recently experienced a rise in measles cases. Its large population and dense urban areas make it vulnerable to rapid transmission should the virus spread from Bangladesh. The ongoing crisis underscores the fragility of immunization gains and the critical importance of sustained vaccination efforts and robust public health infrastructure globally.

Frequently Asked Questions

Read Full Story on Quick Digest